279 related articles for article (PubMed ID: 11862793)
1. [Oral therapy in type 2 diabetes. Critical evaluation of glitazones].
Lotz N
MMW Fortschr Med; 2002 Jan; 144(3-4):48-50. PubMed ID: 11862793
[No Abstract] [Full Text] [Related]
2. [New antidiabetic in "virtual reality". Eye to eye with insulin resistance].
MMW Fortschr Med; 2000 May; 142(19):52. PubMed ID: 10850084
[No Abstract] [Full Text] [Related]
3. [Rosiglitazone (BRL-49653)].
Oka Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():438-41. PubMed ID: 12387030
[No Abstract] [Full Text] [Related]
4. [Clinical efficacy of Pioglitazone (AD-4833)].
Kaneko T; Baba S
Nihon Rinsho; 1997 Nov; 55 Suppl():142-6. PubMed ID: 9434458
[No Abstract] [Full Text] [Related]
5. [Against insulin resistance. Insulin sensitizers].
Verspohl EJ; Weiland F
Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
[No Abstract] [Full Text] [Related]
6. Insulin resistance and beta-cell function--a clinical perspective.
Matthews DR
Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S28-33. PubMed ID: 11685826
[No Abstract] [Full Text] [Related]
7. [Insulin sensitizer drugs--review].
Yamanouchi T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():409-15. PubMed ID: 12387026
[No Abstract] [Full Text] [Related]
8. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
9. [Causal therapy of type 2 diabetes. Determining the cause of insulin resistance early].
MMW Fortschr Med; 2000 Nov; 142(47):56. PubMed ID: 11143782
[No Abstract] [Full Text] [Related]
10. [First insulin sensitizer approved in Germany. Insulin resistance in type 2 diabetes can be treated].
MMW Fortschr Med; 2000 Sep; 142(36):50. PubMed ID: 11021073
[No Abstract] [Full Text] [Related]
11. The rise and fall of troglitazone.
Bailey CJ
Diabet Med; 2000 Jun; 17(6):414-5. PubMed ID: 10975209
[No Abstract] [Full Text] [Related]
12. [Thiazolidinediones--a new class of oral antidiabetics].
Schmitz OE; Brock B; Madsbad S; Beck-Nielsen H
Ugeskr Laeger; 2001 Oct; 163(44):6106-11. PubMed ID: 11715152
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of type 2 diabetes. Blood lipids should not be neglected!].
MMW Fortschr Med; 2000 Nov; 142(44):56. PubMed ID: 11107815
[No Abstract] [Full Text] [Related]
14. Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how.
Gorman C
Time; 2000 Apr; 155(13):94. PubMed ID: 11009709
[No Abstract] [Full Text] [Related]
15. Warner Lambert/Sankyo diabetes drug nears market.
Nat Biotechnol; 1997 Feb; 15(2):113. PubMed ID: 9035120
[No Abstract] [Full Text] [Related]
16. Thiazolidinediones.
Yki-Järvinen H
N Engl J Med; 2004 Sep; 351(11):1106-18. PubMed ID: 15356308
[No Abstract] [Full Text] [Related]
17. [Glitazones--a new class of drugs in treatment of type 2 diabetes].
Kleinwechter H
Dtsch Med Wochenschr; 2002 Feb; 127(8):400-1. PubMed ID: 11859452
[No Abstract] [Full Text] [Related]
18. [Type 2 diabetes. A new kind of insulin sensitizer at the door].
Böhm S
MMW Fortschr Med; 1999 Jul; 141(27):56-7. PubMed ID: 10904588
[No Abstract] [Full Text] [Related]
19. [Pioglitazone].
Kobayashi M; Iwata M; Hiratani K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
[No Abstract] [Full Text] [Related]
20. [Glitazones and weight gain].
Scheen A
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S41-4. PubMed ID: 12037507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
